Managing patient reported outcomes can be time consuming and costly. The iMedNet ePRO module streamlines the process by making onsite and offsite data captures easy for both Patients and Research Coordinators. ePRO allows patients or coordinators to intuitively enter study-related information, and is accessible - anytime, anywhere.
iMedNet is MedNet Solutions’ latest eClinical technology platform. It provides non-technical clinical research personnel with a fast, intuitive and cost-effective solution for building and managing their own clinical studies.
Increase patient engagement and help to ensure compliance during any clinical trial.
The iMedNet Partner Program is designed to help CROs and consulting organizations improve efficiency, expand their service offerings, and win more business.
Streamline real-time data access and analysis with iMedNet's Report Manager.
Improve productivity and minimize risks with iMedNet's Risk Based Monitoring solution.
Bioclinica's Clinical Adjudication Service provides a key role in determining the efficacy and safety endpoints needed to analyze clinical trial outcomes, which are critical in determining a clinical trial’s success.
Bioclinica's Clinical Adjudication Service provides a key role in determining the efficacy and safety endpoints needed to analyze clinical trial outcomes, which are necessary in determining clinical trial success.
Electronic Informed Consent (eConsent) is the next big technological innovation in clinical trials. 146 respondents from 100 biotech, pharmaceutical, CRO, and IRB organizations shared their experiences, expectations, and ideas about the future of eConsent. Whether you’re just starting to consider eConsent or ready to expand adoption, download this report for insight on what is likely to be the next “must-have” in clinical trials.
At 4G, our mission is to move the needle in clinical trials. Our robust, efficient approach to RTSM (Randomization and Trial Supply Management) provides enhanced visibility into your trials, enabling you to do your job better and spend your time and resources wisely to get drugs to patients, faster.
|
|
|
|
|
|
|
|
|